IRCT20160523028008N14 IRCT 2021-04-05 Hamedan University of Medical Sciences The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome The effect Dehydroepiandrosterone (DHEA) supplementation on IVF outcome 2021-05-21 anticipated 80 Complete https://irct.ir/trial/55336 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The patients will be randomly assigned to intervention and control groups using block randomization. For this purpose, we will prepare four sheets of paper, writing on two sheets the name of the intervention and on the other two sheets the name of the control. The paper sheets will be pooled, placed in a container, and randomly drawn one at a time for each patient without replacement until all four sheets are drawn. The four paper sheets will be then placed back into the container, and this action repeated until the sample size is reached, Blinding description: Due to the fact that the drug and placebo are indistinguishable in terms of shape and appearance, patients and the examining physician will not be aware of the type of drug treatment of the patient, so the study will be performed in a double-blind manner. 2-3 Female infertility. Intervention 1: Dehydroepiandrosterone pharmaceutical tablet manufacturing company Puritant`pride USA, 25 mg orally three times in 8 weeks before embryo transfer in patients undergoing IVF are given. Intervention 2: Control group: Administration of placebo (starch tablets) three times a day for 8 weeks. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information"